在表达高水平膜相关叶酸结合蛋白的人KB细胞中鉴定出一种还原型叶酸/甲氨蝶呤载体。 - Suppr | 超能文献

Identification of a reduced folate/methotrexate carrier in human KB-cells expressing high levels of membrane associated folate binding protein.

作者信息

Westerhof G R, Schornagel J H, Rijnboutt S, Pinedo H M, Jansen G

机构信息

Dept. of Oncology, Free University Hospital, Amsterdam, The Netherlands.

出版信息

Adv Exp Med Biol. 1993;338:771-4. doi: 10.1007/978-1-4615-2960-6_161.

DOI:10.1007/978-1-4615-2960-6_161

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Identification of a reduced folate/methotrexate carrier in human KB-cells expressing high levels of membrane associated folate binding protein.

Adv Exp Med Biol. 1993;338:771-4. doi: 10.1007/978-1-4615-2960-6_161.

2

Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate.

Cancer Chemother Pharmacol. 1996;38(3):281-8. doi: 10.1007/s002800050483.

3

Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.

Cancer Res. 1995 Sep 1;55(17):3795-802.

4

Further studies on a novel class of genetic variants of the L1210 cell with increased folate analogue transport inward. Transport properties of a new variant, evidence for increased levels of a specific transport protein, and its partial characterization following affinity labeling.

J Biol Chem. 1988 Jul 15;263(20):9703-9.

5

The reduced folate/methotrexate carrier and a membrane-associated folate binding protein as transport routes for novel antifolates: structure-activity relationships.

Adv Exp Med Biol. 1993;338:767-70. doi: 10.1007/978-1-4615-2960-6_160.

6

Effects of folate receptor expression following stable transfection into wild type and methotrexate transport-deficient ZR-75-1 human breast cancer cells.

J Biol Chem. 1992 Nov 25;267(33):24140-7.

7

Altered transport of folic acid and antifolates through the carrier mediated reduced folate transport system in a human leukemia cell line resistant to (6R) 5,10-dideazatetrahydrofolic acid (DDATHF).

Adv Exp Med Biol. 1993;338:775-8. doi: 10.1007/978-1-4615-2960-6_162.

8

Determinants of the disparate antitumor effects of (6R)5,10-dideaza-5,6,7,8- tetrahydrofolate and methotrexate toward methotrexate resistant CCRF-CEM cells, characterized by severely impaired antifolate membrane transport.

Adv Exp Med Biol. 1993;338:783-6. doi: 10.1007/978-1-4615-2960-6_164.

9

Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake.

J Biol Chem. 2000 Oct 6;275(40):30855-63. doi: 10.1074/jbc.M003988200.

10

Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates.

Biochem Pharmacol. 1992 Nov 3;44(9):1898-901. doi: 10.1016/0006-2952(92)90089-2.

引用本文的文献

1

Methotrexate delivery via folate targeted dendrimer-based nanotherapeutic platform.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 Sep-Oct;1(5):502-10. doi: 10.1002/wnan.37.

2

Endocytosis of GPI-linked membrane folate receptor-alpha.

J Cell Biol. 1996 Jan;132(1-2):35-47. doi: 10.1083/jcb.132.1.35.